Skip to main content
Erschienen in: Herz 5/2023

31.01.2023 | Original articles

Analysis of risk factors for systemic inflammatory response syndrome in patients after transcatheter aortic valve replacement

verfasst von: Jifang Cheng, Mingqi Dong, Chunjie Wen, Bin Yu, Jiaqi Fan

Erschienen in: Herz | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

Our aim was to determine the risk factors of postoperative systemic inflammatory response syndrome (SIRS) in patients with transcatheter aortic valve replacement (TAVR), identify those with a high risk of SIRS, and help reduce SIRS occurrence.

Methods

A retrospective cohort study was conducted to collect the clinical data of patients who underwent TAVR from January 2014 to December 2019 at a tertiary hospital in Zhejiang Province. The study included 156 men and 94 women. Patients were divided into SIRS and non-SIRS groups. The pre-, intra-, and postoperative indices of the two groups were recorded. The data of the two groups were compared, and univariate analysis was performed. All statistically significant factors were assessed using binary logistic regression analysis to clarify the risk factors of SIRS after TAVR.

Results

Overall, 30 patients developed SIRS after TAVR, with an incidence rate of 12%, an odds ratio (OR) of 0.571, and a 95% confidence interval (CI) of 0.469–0.694 (p = 0.000). There was a significant correlation between SIRS and glucose (OR: 0.823, 95% CI: 0.678–1.000, p = 0.049), albumin (OR: 0.938, 95% CI: 0.881–0.998, p = 0.044), brain natriuretic peptide (OR: 1.000, 95% CI: 1.000–1.000, p = 0.010), sex (OR: 0.412, 95% CI: 0.190–0.892, p = 0.025), and history of hypertension (OR: 0.375, 95% CI: 0.169–0.819, p = 0.014). Multivariate regression analysis demonstrated that age (OR: 1.190, 95%CI: 1.073–1.319, p = 0.001) and body mass index (BMI; OR: 0.559, 95% CI: 0.447–0.698, p = 0.000) were independent risk factors for postoperative SIRS in patients with TAVR.

Conclusion

The incidence of SIRS after TAVR was 12%. There was a significant correlation between SIRS and albumin, glucose, and hypertension. The independent risk factors for SIRS after TAVR were age and BMI.
Literatur
2.
3.
Zurück zum Zitat Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R et al (2021) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention 60(4):727–800. https://doi.org/10.4244/eij-e-21-00009CrossRef Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R et al (2021) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention 60(4):727–800. https://​doi.​org/​10.​4244/​eij-e-21-00009CrossRef
4.
Zurück zum Zitat Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, Pilgrim T, Petrinic T, Nikolakopoulou A, Salanti G et al (2019) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J 40(38):3143–3153. https://doi.org/10.1093/eurheartj/ehz275CrossRefPubMed Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, Pilgrim T, Petrinic T, Nikolakopoulou A, Salanti G et al (2019) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J 40(38):3143–3153. https://​doi.​org/​10.​1093/​eurheartj/​ehz275CrossRefPubMed
7.
Zurück zum Zitat Schwietz T, Behjati S, Gafoor S, Seeger F, Doss M, Sievert H, Zeiher AM, Fichtlscherer S, Lehmann R (2015) Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves. EuroIntervention 10(12):1468–1473. https://doi.org/10.4244/eijy14m06_05CrossRefPubMed Schwietz T, Behjati S, Gafoor S, Seeger F, Doss M, Sievert H, Zeiher AM, Fichtlscherer S, Lehmann R (2015) Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves. EuroIntervention 10(12):1468–1473. https://​doi.​org/​10.​4244/​eijy14m06_​05CrossRefPubMed
9.
10.
14.
Zurück zum Zitat Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Müller C, Vasa-Nicotera M, Grube E, Nickenig G et al (2012) Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 33(12):1459–1468. https://doi.org/10.1093/eurheartj/ehs002CrossRefPubMed Sinning JM, Scheer AC, Adenauer V, Ghanem A, Hammerstingl C, Schueler R, Müller C, Vasa-Nicotera M, Grube E, Nickenig G et al (2012) Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 33(12):1459–1468. https://​doi.​org/​10.​1093/​eurheartj/​ehs002CrossRefPubMed
15.
16.
Zurück zum Zitat Xiang J, He L, Li D, Peng T, Wei S (2021) Analysis of risk factors for systemic inflammatory response syndrome after thoracic aortic repair. J Clin Cardiol 37(05):468–472 Xiang J, He L, Li D, Peng T, Wei S (2021) Analysis of risk factors for systemic inflammatory response syndrome after thoracic aortic repair. J Clin Cardiol 37(05):468–472
17.
Zurück zum Zitat Witberg G, Kornowski R, Vaknin-Assa H, Codner P, Bental T, Yahav D, Goldberg E, Perl L, Schwartzenberg S, Sagie A et al (2021) Temporary trends in fever following transcatheter aortic valve implantation. Cardiology 146(3):359–367. https://doi.org/10.1159/000511621CrossRefPubMed Witberg G, Kornowski R, Vaknin-Assa H, Codner P, Bental T, Yahav D, Goldberg E, Perl L, Schwartzenberg S, Sagie A et al (2021) Temporary trends in fever following transcatheter aortic valve implantation. Cardiology 146(3):359–367. https://​doi.​org/​10.​1159/​000511621CrossRefPubMed
19.
Zurück zum Zitat Cheng J, Wen C, Jiang S, Zhu X, Zhang L, Chen S, Liu X, He W, Kong M, Fan J (2021) Study on risk factors of systemic inflammatory response syndrome after transcatheter aortic valve replacement. Chin J Emerg Med 30(12):1506–1509 Cheng J, Wen C, Jiang S, Zhu X, Zhang L, Chen S, Liu X, He W, Kong M, Fan J (2021) Study on risk factors of systemic inflammatory response syndrome after transcatheter aortic valve replacement. Chin J Emerg Med 30(12):1506–1509
21.
Zurück zum Zitat Yuan Y, Huang T, Wang G (2012) Relationship between pulmonary infection and metabolic syndrome after cardiac valve replacement in women. Chin J Nosocomiol 22(12):2545–2546 Yuan Y, Huang T, Wang G (2012) Relationship between pulmonary infection and metabolic syndrome after cardiac valve replacement in women. Chin J Nosocomiol 22(12):2545–2546
Metadaten
Titel
Analysis of risk factors for systemic inflammatory response syndrome in patients after transcatheter aortic valve replacement
verfasst von
Jifang Cheng
Mingqi Dong
Chunjie Wen
Bin Yu
Jiaqi Fan
Publikationsdatum
31.01.2023
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 5/2023
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-023-05163-9

Weitere Artikel der Ausgabe 5/2023

Herz 5/2023 Zur Ausgabe

Herzstillstand nach Energy-Drinks

18.06.2024 Plötzlicher Herztod Nachrichten

Energy-Drinks können sich in Kombination mit anderen Risikofaktoren offenbar zu einem „perfekten Sturm“ zusammenbrauen, der schlimmstenfalls in einen plötzlichen Herzstillstand mündet. Sieben solcher Fälle schildert ein auf Rhythmusstörungen spezialisiertes US-Team.

Schleifendiuretikum ohne Herzinsuffizienz? Verordnung hinterfragen!

18.06.2024 Diuretika Nachrichten

Werden Schleifendiuretika häufig ohne sorgfältige Diagnostik verschrieben? Eine Kohortenstudie aus Schottland scheint darauf hinzudeuten.

Was eine zu kleine Klappe für die Langzeitprognose bedeutet

18.06.2024 Aortenklappenersatz Nachrichten

Stellt sich nach der Implantation eines biologischen Aortenklappenersatzes die Prothese als zu klein für den Patienten heraus, hat das offenbar nur geringe Auswirkungen auf Langzeitüberleben und Reoperationsrisiko; zumindest solange die effektive Öffnungsfläche über 0,65 cm2/m2 liegt.

Vorteile für Blutdruckselbstmanagement

18.06.2024 Hypertonie Nachrichten

Kontrollieren Hypertoniker ihren Blutdruck regelmäßig selbst, und passen sie entsprechend eigenständig ihre Antihypertensivadosis an, wird der Blutdruck um etwa 3 mmHg stärker gesenkt als unter dem üblichen ärztlichen Therapieplan.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.